Silencing of π-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 225, doi. 10.1002/pros.10093
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2002 AND VI 51 AND IP 4
Results: 8
1
2
Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 247, doi. 10.1002/pros.10086
- By:
- Publication type:
- Article
3
Stat3 activation in prostatic carcinomas.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 241, doi. 10.1002/pros.10079
- By:
- Publication type:
- Article
4
Relative promoter strengths in four human prostate cancer cell lines evaluated by particle bombardment-mediated gene transfer.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 286, doi. 10.1002/pros.10081
- By:
- Publication type:
- Article
5
Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 276, doi. 10.1002/pros.10092
- By:
- Publication type:
- Article
6
Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 231, doi. 10.1002/pros.10095
- By:
- Publication type:
- Article
7
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 268, doi. 10.1002/pros.10083
- By:
- Publication type:
- Article
8
Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma.
- Published in:
- Prostate, 2002, v. 51, n. 4, p. 256, doi. 10.1002/pros.10065
- By:
- Publication type:
- Article